NeuroOne Regains Compliance with Nasdaq Minimum Bid Price Requirement
NeuroOne Medical Technologies Corporation announced it has regained compliance with Nasdaq's minimum bid price rule following a 1-for-6 reverse stock split, ensuring its continued listing on the Nasdaq Capital Market.
